Retail News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Retail Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
RetailNewsAS Watson Parent Mulls Bid for Collapsed Australian Pharmacy Group’s Assets
AS Watson Parent Mulls Bid for Collapsed Australian Pharmacy Group’s Assets
RetailM&A

AS Watson Parent Mulls Bid for Collapsed Australian Pharmacy Group’s Assets

•February 23, 2026
0
Inside Retail Asia
Inside Retail Asia•Feb 23, 2026

Why It Matters

Entering Australia would diversify AS Watson’s geographic footprint and accelerate consolidation in the competitive health‑and‑beauty retail sector, potentially reshaping market dynamics.

Key Takeaways

  • •AS Watson eyeing 92 Australian Priceline locations.
  • •Deal valued at minimum AU$500 million.
  • •Would mark AS Watson's first Australian foothold.
  • •Infinity's receivership follows Wesfarmers' store closures.
  • •CK Hutchison backs potential acquisition through AS Watson.

Pulse Analysis

AS Watson’s interest in the Australian Priceline network reflects a broader trend of Asian retailers seeking growth beyond saturated home markets. Backed by CK Hutchison, the Hong Kong health‑and‑beauty giant has expanded aggressively across Southeast Asia, leveraging its loyalty platform and supply‑chain efficiencies. An Australian foothold would not only diversify revenue streams but also provide a platform to introduce its digital‑first retail model to a market where consumers are increasingly favoring omnichannel experiences.

The 92 stores up for sale stem from Infinity Pharmacy Group’s financial collapse, a situation exacerbated by Wesfarmers’ decision to place half of the franchisee’s locations into receivership last December. Infinity’s assets, managed by Teneo, carry a minimum price tag of AU$500 million, indicating the perceived value of the brand footprint and existing lease agreements. For Wesfarmers, offloading the distressed franchisee helps streamline the Priceline brand while preserving its core operations, and it opens the door for a well‑capitalized buyer to stabilize the locations.

If AS Watson secures the acquisition, the competitive landscape could shift markedly. Existing Australian pharmacy chains such as Chemist Warehouse and Priceline’s corporate stores would face a new, globally‑scaled player with deep data analytics and cross‑border sourcing power. Regulatory scrutiny may focus on foreign ownership and consumer protection, but the transaction could also spur investment in store refurbishments and digital integration, benefitting shoppers through broader product assortments and loyalty incentives. Ultimately, the deal could accelerate consolidation in the sector, setting a precedent for further foreign entrants seeking to capture market share in Australia’s robust retail environment.

AS Watson parent mulls bid for collapsed Australian pharmacy group’s assets

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...